Figure 1. SRSD107 Phase 1 Clinical Results: Sustained, dose-dependent pharmacodynamic response to therapy

CRSP SIRIUS PR Fig 1

Figure 1. SRSD107 Phase 1 Clinical Results: Sustained, dose-dependent pharmacodynamic response to therapy

Format

JPEG

Quelle:

CRISPR Therapeutics AG

Downloads